| 000 | 00827nam a2200253#a 4500 | ||
|---|---|---|---|
| 001 | 0000025456 | ||
| 002 | 2714 | ||
| 003 | NIH | ||
| 005 | 20240220140756.0 | ||
| 008 | 240220s1997 xx 000 0 eng d | ||
| 020 | _a9283230019 | ||
| 040 | _aIKU | ||
| 041 | _aeng | ||
| 082 | _aW1 | ||
| 245 | 0 |
_aNon-steroidal anti-inflammatory drugs/ _c(IARC Working Group on the Evaluation of Cancer Preventive Agents) (1997 : Lyon, France) |
|
| 250 | _a(IARC handbooks of cancer prevention; 1) | ||
| 260 |
_aLyon, France: _bInternational Agency for Research on Cancer: _bWorld Health Organization, _c1997 |
||
| 300 |
_axi, 202p.: _bill.; _c24cm |
||
| 650 | 1 | 0 |
_aAnti-inflammatory Agents, Non-Steroidal _xcongresses |
| 650 | 2 | 0 |
_aAspirin _xcongresses |
| 650 | 2 | 0 |
_aPiroxicam _xcongresses |
| 650 | 2 | 0 |
_aSulindac _xcongress |
| 942 | _cOS | ||
| 999 |
_c17513 _d17513 |
||